Qasim, W. (2019). Allogeneic CAR T cell therapies for leukemia - R1. Am J Hematol. doi:10.1002/ajh.25399

Georgiadis, C., Preece, R., Gkazi, A. -. S., Christi, A., Etuk, A., & Qasim, W. (2019). Combinational T Cell Genome Modifications through Vector Coupled and Uncoupled Chemical Deamination. Presented at: 22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT).

Preece, R., Georgiadis, C., Etuk, A., & Qasim, W. (2019). CRISPR-CAR Lentiviral Vector Coupling Transgene Expression with Targeted Cas9 Cleavage for the Engineering of Universal T Cells. Presented at: British-Society-for-Gene-and-Cell-Therapy Autumn Conference.

Naso, G., Petrova, A., & Qasim, W. (2019). CRISPR/Cas9 genome editing of RDEB mutation hotspot. Presented at: British-Society-for-Gene-and-Cell-Therapy Autumn Conference.

Qasim, W. (2019). Genome engineered T cells for blood malignancies. Presented at: British-Society-for-Gene-and-Cell-Therapy Autumn Conference.

Petrova, A., Georgiadis, C., Naso, G., Fleck, R., Allison, L., McGrath, J., . . . Qasim, W. (2019). Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras. Presented at: 22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT).

Gregory, L. C., Ferreira, C. B., Young-Baird, S. K., Williams, H. J., Harakalova, M., van Haaften, G., . . . Dattani, M. T. (2019). Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism with glucose dysregulation. EBioMedicine. doi:10.1016/j.ebiom.2019.03.013

Elfeky, R., Shah, R. M., Unni, M. N., Ottaviano, G., Rao, K., Chiesa, R., . . . Veys, P. (2019). New graft manipulation strategies improved outcome of mismatched stem cell transplantation in children with primary immunodeficiencies. J Allergy Clin Immunol. doi:10.1016/j.jaci.2019.01.030

Etuk, A., Georgiadis, C., Preece, R., & Qasim, W. (2019). Universal antibody-mediated cell therapy (uACT). Presented at: British-Society-for-Gene-and-Cell-Therapy Autumn Conference.

Preece, R., Georgiadis, C., Etuk, A., Christi, A., & Qasim, W. (2019). Vectorised 'Mini' hU6 Pol III Promoter Exhibits Nucleosome Redundancy and Supports Multiplexed CRISPR Guide Expression. Presented at: 22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT).